Almonertinib With Chemotherapy in mEGFR NSCLC

Clinical trial NCT04646824 · UNKNOWN

Trial details

NCT number: NCT04646824
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Metastatic

Start date: 2020-11-19
Primary completion: 2020-11-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.